According to a new report from Intel Market Research, the global Orthobiologics market was valued at USD 6.8 billion in 2025 and is projected to reach USD 12.4 billion by 2034, exhibiting a robust CAGR of 6.8% during the forecast period (2026–2034). This growth is driven by the increasing prevalence of musculoskeletal disorders, an aging global population, and rapid advancements in...